Genomewide scan and fine mapping of quantitative trait loci for intraocular pressure on 5q and 14q in West Africans

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 8, 2006, Pages 3262-3267

  Rotimi, Charles N ^a   Chen, Guanjie ^a   Adeyemo, Adebowale A ^a   Jones, Leslie S ^a   Agyenim Boateng, Kofi ^b   Eghan Jr , Benjamin A ^b   Zhou, Jie ^a   Doumatey, Ayo ^a   Lashley, Karrie ^a   Huang, Hanxia ^a   Fasanmade, Olufemi ^c   Akinsola, Folasade B ^c   Ezepue, Felix ^d   Amoah, Albert ^e   Akafo, Stephen ^e   Chen, Yuanxiu ^a   Oli, Johnnie ^d   Johnson, Thomas ^c  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^c UNIVERSITY OF LAGOS   (Nigeria)

^d UNIVERSITY OF NIGERIA   (Nigeria)

^e UNIVERSITY OF GHANA   (Ghana)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICA; AFRICAN AMERICAN; AGED; ARTICLE; BLINDNESS; CHROMOSOME 14; CHROMOSOME 14Q; CHROMOSOME 5; CHROMOSOME 5Q; DIABETES MELLITUS; EVOLUTION; FEMALE; GENE; GENE LOCUS; GENE MAPPING; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GHANA; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NIGERIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OCULOPLETHYSMOGRAPHY; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; SHORT TANDEM REPEAT; WDR36 GENE; CHROMOSOME MAP; ETHNOLOGY; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; GENOME; MIDDLE AGED; RISK;

CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 5; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GHANA; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; LOD SCORE; MALE; MIDDLE AGED; NIGERIA; ODDS RATIO; QUANTITATIVE TRAIT LOCI;

EID: 33748115162     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-1537     Document Type: Article

References (40)

1. Racette L, Wilson MR, Zangwill LM, Weinreb RN, Sample PA. Primary open-angle glaucoma in blacks: a review. Surv Ophthalmol. 2003;48:295-313.
2. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80:389-393.
3. Quigley HA, Vitale S. Models of open-angle glaucoma prevalence and incidence in the United States. Invest Ophthalmol Vis Sci. 1997;38:83-91.
4. Monemi S, Spaeth G, DaSilva A, et al. Identification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1. Hum Mol Genet. 2005;15;14:725-733.
5. Libby TR, Gould BD, Anderson GM, John WMS. Complex genetics of glaucoma susceptibility. Annu Rev Genomics Hum Genet. 2005;6:15-44. 11.
6. Marier PC, Funk J, Schwarzer G, Antes G, Falck-Ytter YT. Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomized controlled trials. BMJ. 2005;331:134.
7. Fraser SG. Epidemiology of primary open angle glaucoma. In: Hitchings RA, ed. Glaucoma. London: BMJ Publishers; 2000:9-15.
8. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701-713.
9. Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M. Early Manifest Glaucoma Trial Group: reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120:1268-1279.
10. Collaborative Normal Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal tension glaucoma. Am J Ophthalmol. 1998;126:498-505.
11. Shin DH, Becker B. HLA-A11 and HLA-BW35 and resistance to glaucoma in white patients with ocular hypertension. Arch Ophthalmol. 1977;95:423-424.
12. Wilson MR, Hertzmark E, Walker AM, Childs-Shaw K, Epstein DL. A case-control study of risk factors in open angle glaucoma. Arch Ophthalmol. 1987;105:1066-1071.
13. Charliat G, Jolly D, Blanchard F. Genetic risk factor in primary open-angle glaucoma: a case-control study. Ophthalmic Epidemiol. 1994;1:131-138.
14. Perkins ES. Family studies in glaucoma. Br J Ophthalmol. 1997;58:529-535.
15. Wiggs JL, Allingham RR, Hossain A, et al. Genome-wide scan for adult onset primary open angle glaucoma, Hum Mol Genet. 2000;12:9:1109-1117.
16. Stoilova D, Child A, Trifan OC, Crick RP, Coakes RL, Sarfarazi M. Localization of a locus (GLC1B) for adult-onset primary open angle glaucoma to the 2cent-q13 region. Genomics. 1996;36:142-150.
17. Stone EM, Fingert JH, Alward WL, et al. Identification of a gene that causes primary open angle glaucoma. Science. 1997;275:668-670.
18. Wirtz MK, Samples JR, Kramer PL, et al. Mapping a gene for adult-onset primary open angle glaucoma to chromosome 3q. Am J Hum Genet. 1997;60:296-304.
19. Wiggs JL, Lynch S, Ynagi G, et al. A genomewide scan identifies novel early-onset primary open-angle glaucoma loci on 9p22 and 20p12. Am J Hum Genet. 2004;74:1314-1320.
20. Sheffield VC, Stone EM, Alward WL, et al. Genetic linkage of familial open angle glaucoma to chromosome 1q21-q31. Nat Genet. 1993;4:47-50.
21. Trifan OC, Traboulsi EI, Stoilova D, et al. A third locus (GLC1D) for adult onset primary open angle glaucoma maps to the 8q23 region. Am J Ophthalmol. 1998;126:17-28.
22. Sarfarazi M, Child A, Stoilova D, et al. Localization of the fourth locus (GLC1E) for adult-onset primary open-angle glaucoma to the 10p15-p14 region. Am J Hum Genet. 1998;62:641-652.
23. Wirtz MK, Samples JR, Rust K, et al. GLC1F, a new primary open angle glaucoma locus, maps to 7q35-q36. Arch Ophthalmol. 1999;117:237-241.
24. Rezaie T, Child A, Hitchings R, et al. Adult-onset primary open angle glaucoma caused by mutations in optineurin. Science. 2002;295:983-984.
25. Nemesure B, Wu SY, Hennis A, Leske MC. Barbados Eye Studies Group: factors related to the 4-year risk of high intraocular pressure: the Barbados Eye Studies. Arch Ophthalmol. 2003;121:856-862.
26. Rotimi C, Dunston GM, Berg K, et al. In search of susceptibility genes for type 2 diabetes in West Africa: the design and results of the first phase of the AADM study. Ann Epidemiol. 2001;11:51-58.
27. Rotimi C, Chen G, Adeyemo A, et al. A genome-wide search for type 2 diabetes susceptibility genes in West Africans. Diabetes. 2004;53:1-4.
28. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet. 1998;62:1198-1211.
29. Allison BD, Neale CM, Zannolli R, Schork N, Amos IC, Blangero J. Testing the robustness of the likelihood-ratio test in a variance-component quantitative-trail loci-mapping procedure. Am J Hum. 1999;65:531-544.
30. Kissebah AH, Sonnenberg GE, Myklebust J, et al. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndeome. Proc Natl Acad Sci USA. 2000;97:14478-14483.
31. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet. 1995;11:241-247.
32. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. Merlin - rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet. 2002;30:97-101.
33. Fan BJ, Wang DY, Lam DS, Pang CP. Gene mapping for primary open angle glaucoma. Clin Biochem. 2006;39:249-258.
34. Duggal P, Klein AP, Lee KE, et al. A genetic contribution to intraocular pressure: the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci. 2005;46:555-560.
35. Brody LC, Conley M, Cox C, et al. A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/ methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: report of the Birth Defects Research Group. Am J Hum Genet. 2002;71:1207-1215.
36. Bleich S, Junemann A, von Ahsen N, et al. Homocysteine and risk of open-angle glaucoma. J Neural Transm. 2002;109:1499-1504.
37. Leibovitch I, Kurtz S, Shemesh G, et al. Hyperhomocystinemia in pseudoexfoliation glaucoma. J Glaucoma. 2003;12:36-39.
38. Vessani RM, Ritch R, Liebmann JM, Jofe M. Plasma homocysteine is elevated in patients with exfoliation syndrome. Am J Ophthalmol. 2003;136:41-46.
39. Giusti B, Porciani MC, Brunelli T, et al. Phenotypic variability of cardiovascular manifestations in Marfan syndrome: possible role of hyperhomocysteinemia and C677T MTHFR gene polymorphism. Eur Heart J. 2003;24:2038-2045.
40. Altshuler D, Brooks LD, Chakravarti A, Collins FS, Daly MJ, Donnelly P. International HapMap Consortium: a haplotype map of the human genome. Nature. 2005;27;437:1299-1320.